Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.

Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.

Taispeáin leaganacha eile (1)

Ovarian cancer (OC) is a lethal gynecological malignancy with a five-year survival rate of only 46%. Development of resistance to platinum-based chemotherapy is a common cause of high mortality rates among OC patients. Tumor and transcriptomic heterogeneity are drivers of platinum resistance in OC....

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Shruthi Sriramkumar, Tara X Metcalfe, Tim Lai, Xingyue Zong, Fang Fang, Heather M O'Hagan, Kenneth P Nephew
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science (PLoS) 2022-01-01
Sraith:	PLoS ONE
Rochtain ar líne:	https://doi.org/10.1371/journal.pone.0271584

Míreanna comhchosúla

Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment
de réir: Shruthi Sriramkumar, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer
de réir: Shruthi Sriramkumar, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Methylomic Signatures of High Grade Serous Ovarian Cancer
de réir: Horacio Cardenas, et al.
Foilsithe / Cruthaithe: (2021-11-01)

A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer
de réir: Pietro Lo Riso, et al.
Foilsithe / Cruthaithe: (2020-10-01)

A single-cell landscape of high-grade serous ovarian cancer
Foilsithe / Cruthaithe: (2021)

A single-cell landscape of high-grade serous ovarian cancer
de réir: Izar, Benjamin, et al.
Foilsithe / Cruthaithe: (2022)

TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
de réir: Jung-Chien Cheng, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
de réir: Hidenori Machino, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Immune cell landscapes are associated with high-grade serous ovarian cancer survival
de réir: Guoan Zhang, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
de réir: Qian Hao, et al.
Foilsithe / Cruthaithe: (2021-08-01)

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
de réir: Wenying Chen, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
de réir: Miku Wada, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
de réir: Shuang Zhang, et al.
Foilsithe / Cruthaithe: (2019-11-01)

EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?
de réir: Jung-Chien Cheng, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
de réir: Jun Jiang, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models
de réir: Victoria Heredia-Soto, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
de réir: Joshua Brand, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq.
de réir: Andrew J Shih, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry
de réir: Veronica D. Gonzalez, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
de réir: Kosuke Kanno, et al.
Foilsithe / Cruthaithe: (2024-08-01)

PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer
de réir: Emily Lee, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
de réir: Ali R. Özeş, et al.
Foilsithe / Cruthaithe: (2017-04-01)

Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma
de réir: Andrea Flesken-Nikitin, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
de réir: Julia McAdams, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
de réir: Jie Zhang, et al.
Foilsithe / Cruthaithe: (2022-07-01)

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line
de réir: Rodrigo Fernandes da Silva, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
de réir: Hao Huang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.
de réir: Olga Kim, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma
de réir: Nguyen Thuy Linh, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer
de réir: Haixia Luo, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas
de réir: Kawaljit Kaur, et al.
Foilsithe / Cruthaithe: (2024-06-01)

NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
de réir: Cassie Liu, et al.
Foilsithe / Cruthaithe: (2024-05-01)

RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells
de réir: Yuanzhi Chen, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
de réir: Yaxun Jia, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Identification of aberrantly expressed long non‐coding RNAs in ovarian high‐grade serous carcinoma cells
de réir: Kengo Nakashima, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases
de réir: Tanja Pejovic, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line—IPO43
de réir: Fernanda Silva, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro
de réir: Paweł Uruski, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma.
de réir: Jared Ostmeyer, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma
de réir: Daiken Osaku, et al.
Foilsithe / Cruthaithe: (2021-10-01)